rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert F. Apple

Director

Company insider

Files Form 4 as: Director, Kazia Therapeutics; President and CEO, Antares Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
175
Buys
1
Sells
17
Bought
$43K
Sold
$5.8M
Companies
2
Companies where not an officer
1
First trade
16 Jan 2007
Last trade
8 Jan 2026
Last filed
8 Jul 2026

Companies traded

Where they are an officer
Antares PharmaDirector, Officer · last 24 May 20221 buy · 17 sells
Everywhere else they filed: board seats, 10% stakes, other companies
KZIA Kazia TherapeuticsDirector · Biotechnology · last 8 Jan 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month. 2 lines have no legible date and are left out.

Every trade

TradedCompanyWhatAmount
8 Jan 2026filed 8 Jul 2026KZIA Kazia Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
8 Jan 2026filed 8 Jul 2026KZIA Kazia Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—21,658filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—56,300filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—288,786filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—773,700filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—725,751filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—591,510filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—567,423filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—776,617filing
24 May 2022filed 26 May 2022Antares Pharmaoption or derivativeSEC FORM 4 Code D—474,629filing
24 May 2022filed 26 May 2022Antares PharmaSEC FORM 4 Code D$10.5M1,876,693 at $5.60filing
24 May 2022filed 26 May 2022Antares PharmaSEC FORM 4 Code D$3.4M611,667 at $5.60filing
24 May 2022filed 26 May 2022Antares PharmaSEC FORM 4 Code D$2.1M374,099 at $5.60filing
3 Mar 2022filed 4 Mar 2022Antares PharmaSEC FORM 4 Code A—86,814 at $0.00filing
3 Mar 2022filed 4 Mar 2022Antares PharmaSEC FORM 4 Code F$143K37,695 at $3.80filing
16 Feb 2022filed 18 Feb 2022Antares PharmaSEC FORM 4 Code A—76,893 at $0.00filing
16 Feb 2022filed 18 Feb 2022Antares PharmaSEC FORM 4 Code F$125K34,282 at $3.66filing
13 Jun 2021filed 14 Jun 2021Antares PharmaSEC FORM 4 Code F$182K40,892 at $4.45filing
11 Jun 2021filed 14 Jun 2021Antares PharmaSEC FORM 4 Code F$260K58,317 at $4.45filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed18

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.